Inscription Capital’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.75M Sell
10,969
-398
-4% -$121K 0.42% 43
2026
Q1
$2.43M Sell
11,367
-2,494
-18% -$558K 0.26% 68
2025
Q4
$2.37M Sell
13,861
-90
-0.6% -$14K 0.24% 67
2025
Q3
$1.87M Buy
13,951
+5,128
+58% +$543K 0.2% 77
2025
Q2
$859K Buy
+8,823
New +$700K 0.12% 122
2024
Q3
$273K Buy
3,340
+600
+22% +$52.2K 0.04% 293
2024
Q2
$292K Buy
+2,740
New +$263K 0.05% 253
2022
Q1
– Sell
-3,280
Closed -$236K – 208
2021
Q4
$236K Buy
+3,280
New +$206K 0.06% 197

Other funds holding LRCX

Inscription Capital's LRCX Position: Q2 2026 in Review

Inscription Capital reduced its Lam Research (LRCX) stake by 3.5% in Q2 2026, selling an estimated $121K and leaving 10,969 shares worth $4.75M. The position accounts for 0.42% of the portfolio, ranked #43.

Inscription Capital first reported a position in LRCX in Q4 2021 and has held it in 8 quarters since. 3,146 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Inscription Capital held 10,969 shares of Lam Research worth $4.75M as of Q2 2026.
  • Inscription Capital sold 398 Lam Research shares in Q2 2026, an estimated $121K.
  • Lam Research made up 0.42% of Inscription Capital's portfolio in Q2 2026, its #43 holding.
  • Inscription Capital first reported a position in Lam Research in Q4 2021 and has held it in 8 quarters since.
  • 3,146 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.